無料セミナー : 2018年10月2日『プレシジョン・メディシンの戦略的分析、将来動向予測』 BIS Research共同開催

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

中国の分子診断市場の検査件数:腫瘍検査、感染症検査、遺伝子検査

China Molecular Diagnostics Market, Volume, by Application: Oncology Testing (Breast Cancer, Colorectal Cancer, Prostate Cancer), Infectious Disease Testing (Virology, HPV), and Genetic Disease Testing (Blood Screening, HLA)

発行 Renub Research 商品コード 344768
出版日 ページ情報 英文 100 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.61円で換算しております。
Back to Top
中国の分子診断市場の検査件数:腫瘍検査、感染症検査、遺伝子検査 China Molecular Diagnostics Market, Volume, by Application: Oncology Testing (Breast Cancer, Colorectal Cancer, Prostate Cancer), Infectious Disease Testing (Virology, HPV), and Genetic Disease Testing (Blood Screening, HLA)
出版日: 2018年08月17日 ページ情報: 英文 100 Pages
概要

中国の分子診断市場は、2024年末までに18億米ドルに達すると予測されています。

当レポートでは、中国の分子診断市場について調査分析し、市場と予測、検査件数と予測、セグメント別の市場シェアと予測、セグメント別の検査件数シェアと予測、民間の臨床検査室・診断サービスのプロファイル、成長促進要因、課題について、体系的な情報を提供しています。

第1章 エグゼクティブサマリー

第2章 中国の分子診断市場と検査件数

  • 中国の分子診断市場
  • 中国の分子診断検査件数

第3章 市場シェア - 中国の分子診断検査件数シェア分析

  • セグメント別
  • 疾患
  • 腫瘍検査
  • 遺伝子検査
  • 感染症検査

第4章 検査件数シェア - 中国の分子診断

  • セグメント別
  • 疾患
  • 腫瘍検査
  • 遺伝子検査
  • 感染症検査

第5章 疾患 - 中国の分子診断検査件数

  • 腫瘍検査件数
    • 乳癌
    • 直腸癌
    • 前立腺癌
  • 感染症検査件数
    • ウイルス
    • HPV
  • 遺伝子検査件数
    • 血液スクリーニング
    • HLA

第6章 疾患 - 中国の分子診断市場

  • 腫瘍検査市場
  • 感染症検査市場
  • 遺伝子検査市場

第7章 中国の医療保険スキーム

  • 中国の医療保険スキーム

第8章 成長促進要因

第9章 課題

第10章 主な民間臨床検査室・診断サービス企業のプロファイル

  • Zhejiang Di'an Diagnostics Technology Co., Ltd.
  • ADICON Clinical Laboratories (Privately held)
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global (Privately held)
  • BGI-Shenzhen
  • OriGene Technologies
目次

China Molecular Diagnostics Market is projected to reach US$ 1.8 Billion by the end of year 2024 . Molecular diagnostics is a technique which is used for the molecular biological detection of any change in the structure or expression of patient's genetic material. Molecular diagnostics plays an essential role in the detection and identification of various diseases and has gained more public & healthcare specialist attention than ever before. Today, Molecular diagnostics is changing the face of clinical laboratories by offering easy to use automated molecular systems that provide rapid results with less hands-on time.

China Molecular Diagnostics Market is growing rapidly due to the rising incidence of cancer and infectious diseases in the region. In addition; growing wealthy middle class population, who now are willing to pay more in availing better healthcare facilities and aging population who are more vulnerable to communicable diseases and the development in Chinese healthcare infrastructure are some other factors which are expected to drive China Molecular Diagnostics Market to a new record in the forthcoming years.

Renub Research report titled "China Molecular Diagnostics Market, Volume, by Application [Oncology Testing (Breast Cancer, Colorectal Cancer, Prostate Cancer), Infectious Disease Testing (Virology, HPV), and Genetic Disease Testing (Blood Screening, HLA)] " provides a complete analysis of China Molecular Diagnostics Market.

By Application - Oncology and Infectious Disease Driving the China Molecular Diagnostics Market

The report studies the market and volume of the following Molecular Diagnostics segments: Oncology Testing (Breast Cancer, Colorectal Cancer, Prostate Cancer), Infectious Disease Testing (Virology, HPV) and Genetic Disease Testing (Blood Screening, HLA). Due to the rising cancer cases and infectious diseases in the China, it is believed that Oncology testing and Infectious disease testing leads the China Molecular Diagnostics Market in terms of both market & volume.

image1

The report China Molecular Diagnostics Market has been studied from 7 viewpoints:

  • 1) Market & Forecast
  • 2) Volume & Forecast
  • 3) Segments - Market Share & Forecast
  • 4) Segments - Volume Share & Forecast
  • 5) Profiles of Private Clinical Labs and Diagnostic Services
  • 6) Growth Drivers for China Molecular Diagnostics
  • 7) Challenges for China Molecular Diagnostics

This market research report provides a complete analysis of the China Molecular Diagnostics Market, Volume, Growth Drivers, Challenges, and their projections for the upcoming years.

Segment Covered in this report are as follows:

Oncology Testing Market and Volume

  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer

Infectious Disease Testing Market and Volume

  • Virology
  • HPV

Genetic Testing Market and Volume

  • Blood Screening
  • HLA

Profiles of Private Clinical Labs and Diagnostic Services Companies in China

  • Zhejiang Di'an Diagnostics Technology Co., Ltd
  • ADICON Clinical Laboratories
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global (Privately held)
  • BGI-Shenzhen (Privately held)
  • OriGene Technologies (Privately held)

Table of Contents

1. Executive Summary

2. China Molecular Diagnostic Market & Test Volume

  • 2.1 China Molecular Diagnostic Market
  • 2.2 China Molecular Diagnostic Test Volume

3. Market Share - China Molecular Diagnostic Volume Share Analysis

  • 3.1 Segments
  • 3.2 Disease
  • 3.3 Oncology Test
  • 3.4 Genetic Test
  • 3.5 Infectious Disease Test

4. Volume Share - China Molecular Diagnostics

  • 4.1 Segments
  • 4.2 Disease
  • 4.3 Oncology Test
  • 4.4 Infectious Disease Test
  • 4.5 Genetic Test

5. Disease - China Molecular Diagnostic Test Volume

  • 5.1 Oncology Test Volume
    • 5.1.1 Breast Cancer Test Volume
    • 5.1.2 Colorectal Cancer Test Volume
    • 5.1.3 Prostate Cancer Test Volume
  • 5.2 Infectious Disease Test Volume
    • 5.2.1 Virology Test Volume
    • 5.2.2 HPV Test Volume
  • 5.3 Genetic Test Volume
    • 5.3.1 Blood Screening Test Volume
    • 5.3.2 HLA Test Volume

6. Disease - China Molecular Diagnostic Market

  • 6.1 Oncology Testing Market
    • 6.1.1 Breast Cancer Testing Market
    • 6.1.2 Colorectal Cancer Testing Market
    • 6.1.3 Prostate Cancer Testing Market
  • 6.2 Infectious Disease Testing Market
    • 6.2.1 Virology Testing Market
    • 6.2.2 HPV Testing Market
  • 6.3 Genetic Testing Market
    • 6.3.1 Blood Screening Market
    • 6.3.2 HLA Testing Market

7. China Healthcare Insurance Schemes

  • 7.1 China Healthcare Insurance Schemes
    • 7.1.1 New Rural Cooperative Medical Scheme (NRCMS)
    • 7.1.2 Urban Employed Basic Medical Insurance (UEBMI)
    • 7.1.3 Urban Resident Basic Medical Insurance (URBMI)
    • 7.1.4 Private Health Insurance

8. Growth Drivers

  • 8.1 Increasing Demand from Middle Class for High Quality Healthcare Products
  • 8.2 Rising Incidences of Lifestyle Diseases in China
  • 8.3 Rapid Development in the Diagnosis of Infectious Diseases in China
  • 8.4 Growth in Private Hospitals & Independent Diagnostic Centers
    • 8.4.1 Increasing the Number of Hospital Beds across all Medical Institutions

9. Challenges

  • 9.1 Lack of Government Support, Public Awareness for Molecular Diagnostics test
  • 9.2 Shortage of Skilled Technicians in China
  • 9.3 Reimbursement Rates varies from Province to Province in China
    • 9.3.1 Chinese Government Regulating Laboratory Testing in China

10. Profiles of Private Clinical Labs and Diagnostic Services Companies

  • 10.1 Zhejiang Di'an Diagnostics Technology Co., Ltd.
    • 10.1.1 Company Overview
    • 10.1.2 Products and Services Offered by Di'an
  • 10.2 ADICON Clinical Laboratories (Privately held)
    • 10.2.1 Company Overview
    • 10.2.2 Products and Services Offered by ADICON
  • 10.3 Guangzhou Kingmed Diagnostics Center Co. Ltd.
    • 10.3.1 Company Overview
    • 10.3.2 Products and Services Offered by Kingmed
  • 10.4 Kindstar Global (Privately held)
    • 10.4.1 Company Overview
    • 10.4.2 Products and Services Offered by Kindstar
  • 10.5 BGI-Shenzhen
    • 10.5.1 Company Overview
    • 10.5.2 BGI's Innovative Approach
  • 10.6 OriGene Technologies
    • 10.6.1 Company Overview
    • 10.6.2 Products and Services Offered by OriGene

List of Figures:

  • Figure 2-1: China - Molecular Diagnostic Market (Billion US$), 2011 - 2017
  • Figure 2-2: China - Forecast for Molecular Diagnostic Market (Billion US$), 2018 - 2024
  • Figure 2-3: China - Molecular Diagnostic Test Volume (Million), 2011 - 2017
  • Figure 2-4: China - Forecast for Molecular Diagnostic Test Volume (Million), 2018 - 2024
  • Figure 3-1: China - Molecular Diagnostic Market Share (Percent), 2011 - 2017
  • Figure 3-2: China - Forecast for Molecular Diagnostic Market Share (Percent), 2018 - 2024
  • Figure 3-3: China - Molecular Oncology Test Market Share (Percent), 2011 - 2017
  • Figure 3-4: China - Forecast for Molecular Oncology Test Market Share (Percent), 2018 - 2024
  • Figure 4-1: China - Molecular Diagnostic Test Volume Share (Percent), 2011 - 2017
  • Figure 4-2: China - Forecast for Molecular Diagnostic Test Volume Share (Percent), 2018 - 2024
  • Figure 4-3: China - Molecular Oncology Test Volume Share (Percent), 2011 - 2017
  • Figure 4-4: China - Forecast for Molecular Oncology Test Volume Share (Percent), 2018 - 2024
  • Figure 5-1: Rural China - Cancer Screening Sites by Cancer Type (Number), 2013
  • Figure 5-2: China - Oncology Test Volume (Million), 2011 - 2017
  • Figure 5-3: China - Forecast for Oncology Test Volume (Million), 2018 - 2024
  • Figure 5-4: China -Breast Cancer Molecular Test Volume (Million), 2011 - 2017
  • Figure 5-5: China - Forecast for Breast Cancer Molecular Test Volume (Million), 2018 - 2024
  • Figure 5-6: China - Colorectal Cancer Test Volume (Million), 2011 - 2017
  • Figure 5-7: China - Forecast for Colorectal Cancer Test Volume (Million), 2018 - 2024
  • Figure 5-8: China -Prostate Cancer Test Volume (Million), 2011 - 2017
  • Figure 5-9: China - Forecast for Prostate Cancer Test Volume (Million), 2018 - 2024
  • Figure 5-10: China - Infectious Disease Test Volume (Million), 2011 - 2017
  • Figure 5-11: China - Forecast for Infectious Disease Test Volume (Million), 2018 - 2024
  • Figure 5-12: China -Virology Test Volume (Million), 2011 - 2017
  • Figure 5-13: China - Forecast for Virology Test Volume (Million), 2018 - 2024
  • Figure 5-14: China -HPV Test Volume (Thousand), 2011 - 2017
  • Figure 5-15: China - Forecast for HPV Test Volume (Thousand), 2018 - 2024
  • Figure 5-16: China -Genetic Test Volume (Million), 2011 - 2017
  • Figure 5-17: China - Forecast for Genetic Test Volume (Million), 2018 - 2024
  • Figure 5-18: China -Blood Screening Test Volume (Million), 2011 - 2017
  • Figure 5-19: China - Forecast for Blood Screening Test Volume (Million), 2018 - 2024
  • Figure 5-20: China - HLA Test Volume (Thousand), 2011 - 2017
  • Figure 5-21: China - Forecast for HLA Test Volume (Thousand), 2018 - 2024
  • Figure 6-1: China -Oncology Testing Market (Million US$), 2011 - 2017
  • Figure 6-2: China - Forecast for Oncology Testing Market (Million US$), 2018 - 2024
  • Figure 6-3: China -Breast Cancer Testing Market (Million US$), 2011 - 2017
  • Figure 6-4: China - Forecast for Breast Cancer Testing Market (Million US$), 2018 - 2024
  • Figure 6-5: China -Colorectal Cancer Testing Market (Million US$), 2011 - 2017
  • Figure 6-6: China - Forecast for Colorectal Cancer Testing Market (Million US$), 2018 - 2024
  • Figure 6-7: China -Prostate Cancer Testing Market (Million US$), 2011 - 2017
  • Figure 6-8: China - Forecast for Prostate Cancer Testing Market (Million US$), 2018 - 2024
  • Figure 6-9: China -Infectious Disease Testing Market (Million US$), 2011 - 2017
  • Figure 6-10: China - Forecast for Infectious Disease Testing Market (Million US$), 2018 - 2024
  • Figure 6-11: China -Virology Testing Market (Million US$), 2011 - 2017
  • Figure 6-12: China - Forecast for Virology Testing Market (Million US$), 2018 - 2024
  • Figure 6-13: China -HPV Testing Market (Million US$), 2011 - 2017
  • Figure 6-14: China - Forecast for HPV Testing Market (Million US$), 2018 - 2024
  • Figure 6-15: China -Genetic Testing Market (Million US$), 2011 - 2017
  • Figure 6-16: China - Forecast for Genetic Testing Market (Million US$), 2018 - 2024
  • Figure 6-17: China -Blood Screening Market (Million US$), 2011 - 2017
  • Figure 6-18: China - Forecast for Blood Screening Market (Million US$), 2018 - 2024
  • Figure 6-19: China - HLA Testing Market (Thousand US$), 2011 - 2017
  • Figure 6-20: China - Forecast for HLA Testing Market (Thousand US$), 2018 - 2024
  • Figure 8-1: China - Healthcare Spending (Billion US$), 2011 & 2020
  • Figure 10-1: Kindstar - Collaboration with Hospitals in China (Number), 2006 - 2012

List of Tables:

  • Table 3-1: China - Molecular Diagnostic Application Market Share (Percent), 2011 - 2017
  • Table 3-2: China - Forecast for Molecular Diagnostic Application Market Share (Percent), 2018 - 2024
  • Table 3-3: China - Molecular Genetic Test Market Share (Percent), 2011 - 2017
  • Table 3-4: China - Forecast for Molecular Genetic Test Market Share (Percent), 2018 - 2024
  • Table 3-5: China - Molecular Infectious Disease Test Market Share (Percent), 2011 - 2017
  • Table 3-6: China - Forecast for Molecular Infectious Disease Test Market Share (Percent), 2018 - 2024
  • Table 4-1: China - Molecular Diagnostic Test Volume Application Share (Percent), 2011 - 2017
  • Table 4-2: China - Forecast for Molecular Diagnostic Test Volume Application Share (Percent), 2018 - 2024
  • Table 4-3: China - Molecular Infectious Disease Test Volume Share (Percent), 2011 - 2017
  • Table 4-4: China - Forecast for Molecular Infectious Disease Test Volume Share (Percent), 2018 - 2024
  • Table 4-5: China - Molecular Genetic Test Volume Share (Percent), 2011 - 2017
  • Table 4-6: China - Forecast for Molecular Genetic Test Volume Share (Percent), 2018 - 2024
  • Table 8-1: China - Major Diagnostic Reagent R&D and Manufacturing Companies in Infectious Diseases, 2010
  • Table 8-2: Number of hospital beds for every 1,000 people
Back to Top